Steris | STE - Des Atouts





Des Atouts Changement Date
3M USD 39.53B 4.6B 2026-09
Accuray USD 448.01M 8.81M 2025-12
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.46B 245M 2026-09
CONMED USD 2.3B 4.16M 2026-09
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.24B 216.5M 2026-09
Ecolab USD 31.11B 1.18B 2026-09
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Fortive USD 11.5B 112.2M 2026-09
Getinge SEK 57.37B 6.55B 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Idexx Laboratories USD 3.71B 264.77M 2026-09
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.51B 55.69M 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 197.42B 3.64B 2026-09
Olympus JPY 1.53T 10.69B 2026-06
Orthofix International USD 873.02M 13.58M 2026-06
Owens Minor USD 2.11B 308.57M 2026-06
ResMed USD 8.21B 754.14M 2026-09
Steris USD 10.74B 1.1M 2026-06
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06